rs199766569
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001139.3(ALOX12B):āc.1562A>Gā(p.Tyr521Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000123 in 1,613,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ).
Frequency
Genomes: š 0.00013 ( 0 hom., cov: 32)
Exomes š: 0.00012 ( 0 hom. )
Consequence
ALOX12B
NM_001139.3 missense
NM_001139.3 missense
Scores
15
3
1
Clinical Significance
Conservation
PhyloP100: 5.57
Genes affected
ALOX12B (HGNC:430): (arachidonate 12-lipoxygenase, 12R type) This gene encodes an enzyme involved in the conversion of arachidonic acid to 12R-hydroxyeicosatetraenoic acid. Mutations in this gene are associated with nonbullous congenital ichthyosiform erythroderma. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.993
PP5
Variant 17-8075687-T-C is Pathogenic according to our data. Variant chr17-8075687-T-C is described in ClinVar as [Pathogenic]. Clinvar id is 39546.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-8075687-T-C is described in Lovd as [Pathogenic]. Variant chr17-8075687-T-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALOX12B | NM_001139.3 | c.1562A>G | p.Tyr521Cys | missense_variant | 12/15 | ENST00000647874.1 | NP_001130.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALOX12B | ENST00000647874.1 | c.1562A>G | p.Tyr521Cys | missense_variant | 12/15 | NM_001139.3 | ENSP00000497784 | P1 | ||
ALOX12B | ENST00000649809.1 | c.626A>G | p.Tyr209Cys | missense_variant | 5/8 | ENSP00000496845 | ||||
ALOX12B | ENST00000577351.5 | n.479+488A>G | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 152036Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
20
AN:
152036
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000195 AC: 49AN: 251486Hom.: 0 AF XY: 0.000213 AC XY: 29AN XY: 135916
GnomAD3 exomes
AF:
AC:
49
AN:
251486
Hom.:
AF XY:
AC XY:
29
AN XY:
135916
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000122 AC: 178AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.000143 AC XY: 104AN XY: 727248
GnomAD4 exome
AF:
AC:
178
AN:
1461894
Hom.:
Cov.:
32
AF XY:
AC XY:
104
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000132 AC: 20AN: 152036Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74234
GnomAD4 genome
AF:
AC:
20
AN:
152036
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74234
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
33
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal recessive congenital ichthyosis 2 Pathogenic:6
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 23, 2014 | The Tyr521Cys variant in ALOX12B has been reported in 8 individuals with clinical features of Autosomal recessive congenital ichthyosis. Four of these individuals were homozygous for this variant, and 3 were compound heterozygous with a second variant in ALOX12B (Eckl, 2005; Valhquist, 2010). This variant was not identified in large population studies. Studies have shown that this variant impacts protein function (Eckl 2009); however this in vitro assay may not accurately represent biological function. Computational analyses suggest that the p.Tyr521Cys variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, this variant meets our criteria to be classified as pathogenic (http://pcpgm.partners.org/LMM). - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory of Medical Genetics, National & Kapodistrian University of Athens | Oct 01, 2021 | PM1, PM2, PP2, PP3, PP4, PP5 - |
Pathogenic, no assertion criteria provided | clinical testing | Institute for Human Genetics, University Medical Center Freiburg | Jan 07, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The ALOX12B c.1562A>G (p. Tyr521Cys) variant has been reported in at least six studies in which it is reported in a total of ten individuals with varying degrees of ichthyosis including four in a homozygous state, five in a compound heterozygous state, and one in a heterozygous state where a second variant was not identified (Eckl et al. 2005; Eckl et al. 2009; Vahlquist et al. 2010; Suresh et al. 2015). The p.Tyr521Cys variant was absent from 390 controls and is reported at a frequency of 0.00060 in the European Finnish population of the Exome Aggregation Consortium. Functional analysis in HEK-293 cells revealed that the variant resulted in protein expression levels comparable to wild type, but complete loss of enzymatic activity (Eckl et al. 2005; Eckl et al. 2009). Based on the evidence, the p.Tyr521Cys variant is classified as pathogenic for congenital ichthyosis. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jan 01, 2016 | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PS3,PM2,PP2,PP3. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2010 | - - |
not provided Pathogenic:6
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Jul 13, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2018 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 11, 2021 | Published functional studies demonstrate this variant results in complete loss of enzymatic activity (Eckl et al., 2005); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 19131948, 22622417, 31230075, 19890349, 25998749, 29444371, 23290633, 31168818, 31589614, 33726816, 27025581, 16116617) - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 521 of the ALOX12B protein (p.Tyr521Cys). This variant is present in population databases (rs199766569, gnomAD 0.04%). This missense change has been observed in individuals with autosomal recessive congenital ichthyosis (PMID: 16116617, 27025581, 31168818). ClinVar contains an entry for this variant (Variation ID: 39546). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ALOX12B protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
Lamellar ichthyosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 04, 2022 | Variant summary: ALOX12B c.1562A>G (p.Tyr521Cys) results in a non-conservative amino acid change located in the Lipoxygenase, C-terminal domain (IPR013819) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00019 in 251486 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in ALOX12B causing Lamellar Ichthyosis (0.00019 vs 0.0009), allowing no conclusion about variant significance. c.1562A>G has been reported in the literature as homozygous and compound heterozygous genotypes in multiple individuals affected with Lamellar Ichthyosis (example, Pigg_2016, Eckl_2005). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no variant specific traceable experimental evidence demonstrating an impact on protein function has been reported. Although one study reported no enzyme activity, the primary data supporting this evidence were not presented (Eckl_2005). Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Ichthyosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jan 01, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H;H;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.;.
REVEL
Pathogenic
Sift
Pathogenic
D;.;.
Sift4G
Pathogenic
D;.;.
Polyphen
D;D;.
Vest4
MutPred
Gain of catalytic residue at S523 (P = 0.0553);Gain of catalytic residue at S523 (P = 0.0553);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at